Cargando…
Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
BACKGROUND: Cisplatin (CDDP) significantly prolongs survival in various cancers, but many patients also develop resistance that results in treatment failure. Thus, this study aimed to elucidate the underlying mechanisms by which ovarian cancer cells acquire CDDP resistance. METHODS: We evaluated the...
Autores principales: | Guo, Jing, Satoh, Kiyotoshi, Tabata, Sho, Mori, Masaru, Tomita, Masaru, Soga, Tomoyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891143/ https://www.ncbi.nlm.nih.gov/pubmed/33596851 http://dx.doi.org/10.1186/s12885-021-07879-5 |
Ejemplares similares
-
Oligodendroglioma Cells Lack Glutamine Synthetase and Are Auxotrophic for Glutamine, but Do not Depend on Glutamine Anaplerosis for Growth
por: Chiu, Martina, et al.
Publicado: (2018) -
Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth
por: Issaq, Sameer H., et al.
Publicado: (2019) -
Leukemia Cells Resistant to Glutamine Deprivation Express Glutamine Synthetase Protein
por: Yücel, Burcu, et al.
Publicado: (2022) -
Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023) -
CLONAL DIFFERENCES IN GLUTAMINE SYNTHETASE ACTIVITY OF HEPATOMA CELLS : Effects of Glutamine and Dexamethasone
por: Kulka, Richard G., et al.
Publicado: (1972)